GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (BSP:VRTX34) » Definitions » Effect of Exchange Rate Changes

Vertex Pharmaceuticals (BSP:VRTX34) Effect of Exchange Rate Changes : R$-6 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vertex Pharmaceuticals Effect of Exchange Rate Changes?

Vertex Pharmaceuticals's Effect of Exchange Rate Changes for the three months ended in Mar. 2024 was R$-78 Mil.

Vertex Pharmaceuticals's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2024 was R$-6 Mil.

Vertex Pharmaceuticals Effect of Exchange Rate Changes Historical Data

The historical data trend for Vertex Pharmaceuticals's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Effect of Exchange Rate Changes Chart

Vertex Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.57 105.98 -75.78 -153.17 131.81

Vertex Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.50 48.54 -111.12 134.26 -77.69

Vertex Pharmaceuticals Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vertex Pharmaceuticals Effect of Exchange Rate Changes Related Terms

Thank you for viewing the detailed overview of Vertex Pharmaceuticals's Effect of Exchange Rate Changes provided by GuruFocus.com. Please click on the following links to see related term pages.

Vertex Pharmaceuticals (BSP:VRTX34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (BSP:VRTX34) » Definitions » Effect of Exchange Rate Changes
Comparable Companies
REGN MRNA BNTX ALNY BGNE BMRN RPRX SRPT INCY UTHR OCSE:NOVO B ASX:CSL XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX OCSE:GMAB SHSE:603392 SZSE:300122 XKRX:028300
Traded in Other Exchanges
VRTX:USA VRTX:Mexico 1VRTX:Italy VX1d:UK VX1:Germany VRTX:Austria
Address
50 Northern Avenue, Boston, MA, USA, 02210
Website
https://www.vrtx.com
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Vertex Pharmaceuticals (BSP:VRTX34) Headlines

No Headlines